The Patient Is the Product. It’s Time They Were the Customer.

This is part of STVL's ongoing coverage of the consumer health market. We invest early in founders building direct pay solutions, alternative financing models, and consumer empowerment technologies. You can read our full healthcare thesis here.

Capital Factory’s Health Supernova · Austin, TX · May 2026

Two days inside a healthcare innovation conference in the heart of Texas confirmed what we already believe: the infrastructure for a true consumer-first health market is finally being built — and the founders doing it deserve our attention.

By Amina ResheidatHealth CareInvestor, Stand Together Ventures Lab

George W. Bush promised portable health records by 2014. Obama put $30 billion behind electronic health records. The 21st Century Cures Act mandated data interoperability. And yet, as of today, the fax machine remains the number-one way information moves through the American healthcare system.

That’s the backdrop against which I spent two days at a healthcare innovation conference hosted by Capital Factory in Austin, Texas — watching founders pitch, listening to CEOs inspire crowds and moderators alike, and having hallway conversations that cut closer to the truth than most panel discussions I catch at larger conferences. Here’s what stood out most:

The data portability dam is about to break

“Patient Data Independence Day”, coined by HHS and CMS Administrator Dr. Oz is coming this July  — the point at which any patient can use any app they choose (several companies have joined their “health technology ecosystem” to support this choice) to log in once and bypass fragmented patient portals entirely. Whether the implementation lives up to the ambition remains to be seen, but the regulatory tailwind could be real. CMS has an aim to “kill the clipboard” and decades of inefficient and head spinning paperwork at point of care, connect providers and payors better, and give patients actual visibility into what they’re paying for.

The founders building on top of this shift and many others in the health care market are inspiring.  

  • Health Bank One A consumer-owned health data account — think open banking, but for your medical records. Using digital identity and a consumer-direct Model Context Protocol server, they allow any AI agent to access your data on your terms. People have tried and failed at portable and consumer owned health records for years. The tech and time is ready for this to become a reality. The classic argument against this working is that clinics run on paper and changing behavior in the clinic when care teams are overwhelmed with immediate care needs is hard. This company is teaching their models to "speak fax" because that is how they get the highest success rates of pulling all data, records, and images for their users. Instead of trying to change clinic and healthcare provider behavior and adding one more thing to their plate, the startup is outsmarting the archaic system to provide a modern experience for patients.
  • Molecular You A deep biomarker panel at-home testing kit that functions like a check engine light for your body. At $660–$1,099 per test (HSA-eligible), it surfaces drivers of conditions like Alzheimer’s and cancer before they’re clinically present. One story from the founder was revealing: a patient found an early-stage cancer diagnosis through this test, then had to leave the insurance system she’d already paid into,  seeking out a direct-pay concierge doctor to access the care that saved her life. The room seemed to absorb this quietly. The question screaming in my head was, “if innovation will always outpace insurance formularies, benefits, and clinical practice guidelines, why do we keep anchoring to them?”
  • Healthnix Founded after the CEO nearly had an unnecessary hip surgery — with the fragmentation and incentives that exist in the healthcare system, her physician found it more straight forward to schedule her in the OR than to navigate the murky multi-layered system that could address the nutritional causes of her chronic and mysterious pain. Nutrition has been shown to reduce pain by up to 70% in some cases. Healthnix trains physicians in nutrition and pain management and feeds longitudinal patient data back to providers between visits.  
  • Bearable An aggregation layer that pulls together health apps, wearables, Gmail, calendars, and sleep data into a daily report. The play is integration — the connective tissue for consumers becoming increasingly overwhelmed by point solutions. In a world where consumers are increasingly self-monitoring and having to integrate their out-of-system and in-clinic care with their day-to-day lives, the interface that synthesizes it all holds significant leverage.

Founders are ignoring the playbook and transforming problems at their root

Beyond the panels, there were promising signals from the expo floor and first-look pitches. I heard from founders working at the edges of formerly “intractable” problems — categories where conventional thinking had calcified into inertia, and they’ve decided to ignore the established playbook entirely. I don’t just love the ambition — it’s that each of these companies is attacking broken assumptions, not just building a better product.

  • Indipop — More than a marketplace for medical cost-sharing plans — they’re positioning as a health empowerment brand for the 70 million independent professionals in the US who aren’t tethered to employer-sponsored insurance. Low-cost financing for unplanned medical bills. Preserving market economics for cash-paying consumers. Where are they in-network? That question doesn’t apply because providers are giving the best price that matches the demand for their service in their area – no inflated negotiations needed. This is exactly the kind of alternative financing infrastructure we think the direct-pay ecosystem needs.
  • Electrome — The default in pain and oncology has been to medicate — expensive for the system, hard on patients, and increasingly scrutinized. Electrome is selling electrotherapy OTC and to the VA for pain management while cross-subsidizing oncology research through commercial revenue.  
  • CLOAK Biosciences — Mosquito-borne disease kills more humans than any other animal on earth, and the dominant approach has been chemical (deet) repellents and nets for decades. CLOAK is working on a new mechanism of action for mosquito bite defense with dual-use consumer potential that is better for the environment and requires less use.  
  • Senticell — Liquid biopsies through red blood cells rather than traditional tissue sampling, lowering the barrier to early cancer detection.  
  • Stealth Mode Startup — Data centers are consuming energy at a pace that is straining grids and driving up household electricity costs. The conversation has largely been about how to finance more centers and power them more efficiently. This startup is changing the inputs entirely — synthesizing DNA to map and store data in a way that is 1,000x more space and energy efficient than conventional data center infrastructure. I'm particularly interested in what this could mean for households in areas that have been hit hardest by rising energy costs. The new paradigm: biology as computing substrate, not silicon.
  • Eon — The premise sounds like science fiction: mapping the human brain well enough to create a digital replica. But the downstream applications are where it gets commercially interesting. Digital brain models could replace the live animal breeding required for pre-clinical drug studies — faster, cheaper, and more reproducible than today's standard.  

The question nobody asked out loud

“The health system is designed to benefit from your system breaking down.”

That line came from a CEO on the main stage, and the room mostly nodded and moved on. But I believe it to be true as the core premise our work – so I am going to let it sit for longer...

The most telling moment of the two days wasn’t a pitch or a product demo — it was the story of a patient who had to opt out of the insurance system she’d already paid for in order to receive preventive care that may have saved her life.

That’s not a data problem or a technology problem. It’s an incentive problem. And the founders building direct-pay models, consumer-owned data infrastructure, and alternative financing tools are — whether they frame it this way or not — attacking the incentive structure directly.

What we’re watching

Problems in healthcare can be solved by solutions that treat people — not systems — as the customer to serve. When individuals hold their own data, choose their own providers, and finance their own care on competitive terms, the market dynamics that have been suppressed for decades can begin to function.

The regulatory environment is moving. The infrastructure is being built. The founders are early. That’s where we want to be.

If you’re building in consumer health — direct pay models, alternative financing, or transforming how patients can access and manage integrated care — we want to hear from you. And if you’re a co-investor tracking this space, let’s compare notes.

Thank you to our friends at Capital Factory for building the room — and to the founders who filled it with something worth writing about.

Navigate challenges and achieve success

Empower your business with expert guidance